Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 20,000 shares at $41.80 ($836K) on 2018-05-11, disclosed to the SEC on 2018-05-15.
Seasonal sale ($836k) by Director — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |